Clinical research tools in pediatric oncology:: challenges and opportunities
Clinical research tools in pediatric oncology:: challenges and opportunities
Survival for childhood cancers has improved significantly over the last decades. However, patient outcomes have plateaued over the last decade for difficult-to-treat diseases. With high cure rates, decreasing long-term toxicities and sequelae remains crucial. Since many advances in childhood cancer research come from the adult oncology world, one of the key areas is improving the adaptation of tools that are essential for clinical trial conduct and that were developed for adults into pediatrics. These include tools to evaluate toxicity, quality of life, radiological response, statistical methodology, or indicators of cancer care quality. In this review, we present ongoing international efforts to validate and adapt these tools for children and adolescents and discuss remaining challenges. These efforts will hopefully accelerate and improve the quality of pediatric oncology research in the upcoming years.
AYA oncology, CTCAE, Childhood cancer, Quality assurance, Quality of life, RECIST
149-160
de Rojas, Teresa
799aa1fb-52f8-4ecf-973a-632cfce7ad2f
Neven, Anouk
92a2968e-e211-46a9-86a9-6a60d5e6f706
Towbin, Alexander J.
4555295c-e83f-4322-b858-880e02b4d507
Carceller, Fernando
77fc8439-8b41-4aca-b573-84e097d5e8da
Bautista, Francisco
25005ad2-818a-4cb5-975b-bd6fde9abf36
Riedl, David
dd01d4ed-3140-4f77-9923-883a04a4c136
Sodergren, Samantha
d66fc3fa-2c98-403d-8ae5-410ef95de46e
Darlington, Anne-Sophie
472fcfc9-160b-4344-8113-8dd8760ff962
Fernandez-Teijeiro, Ana
ae0b5c7b-b2a0-4105-810b-e68d69f69977
Moreno, Lucas
25f0eebb-928a-4d37-b4ff-6e65aab0ab0e
1 March 2020
de Rojas, Teresa
799aa1fb-52f8-4ecf-973a-632cfce7ad2f
Neven, Anouk
92a2968e-e211-46a9-86a9-6a60d5e6f706
Towbin, Alexander J.
4555295c-e83f-4322-b858-880e02b4d507
Carceller, Fernando
77fc8439-8b41-4aca-b573-84e097d5e8da
Bautista, Francisco
25005ad2-818a-4cb5-975b-bd6fde9abf36
Riedl, David
dd01d4ed-3140-4f77-9923-883a04a4c136
Sodergren, Samantha
d66fc3fa-2c98-403d-8ae5-410ef95de46e
Darlington, Anne-Sophie
472fcfc9-160b-4344-8113-8dd8760ff962
Fernandez-Teijeiro, Ana
ae0b5c7b-b2a0-4105-810b-e68d69f69977
Moreno, Lucas
25f0eebb-928a-4d37-b4ff-6e65aab0ab0e
de Rojas, Teresa, Neven, Anouk, Towbin, Alexander J., Carceller, Fernando, Bautista, Francisco, Riedl, David, Sodergren, Samantha, Darlington, Anne-Sophie, Fernandez-Teijeiro, Ana and Moreno, Lucas
(2020)
Clinical research tools in pediatric oncology:: challenges and opportunities.
Cancer and Metastasis Reviews, 39 (1), .
(doi:10.1007/s10555-020-09856-z).
Abstract
Survival for childhood cancers has improved significantly over the last decades. However, patient outcomes have plateaued over the last decade for difficult-to-treat diseases. With high cure rates, decreasing long-term toxicities and sequelae remains crucial. Since many advances in childhood cancer research come from the adult oncology world, one of the key areas is improving the adaptation of tools that are essential for clinical trial conduct and that were developed for adults into pediatrics. These include tools to evaluate toxicity, quality of life, radiological response, statistical methodology, or indicators of cancer care quality. In this review, we present ongoing international efforts to validate and adapt these tools for children and adolescents and discuss remaining challenges. These efforts will hopefully accelerate and improve the quality of pediatric oncology research in the upcoming years.
Text
Clinical research tools in pediatric oncology challenges and opportunities
- Accepted Manuscript
More information
Accepted/In Press date: 26 December 2019
e-pub ahead of print date: 15 January 2020
Published date: 1 March 2020
Additional Information:
Funding Information:
Teresa de Rojas’ work as Fellow at EORTC Headquarters was supported by a grant from EORTC Cancer Research Fund (ECRF) from Belgium. Fernando Carceller is supported by George and the Giant Pledge via the Royal Marsden Cancer Charity.
Funding Information:
Francisco Bautista had a consultant or advisory role for Bayer, Amgen, and EusaPharma, received honoraria for speaking at symposia from Amgen and Jazz Pharmaceuticals and support for attending symposia from Takeda, EusaPharma, Shire, and Jazz Pharmaceuticals. Ana Fernández-Teijeiro has had a consulting or advisory role for Amgen, Novartis, Takeda, SOBI and Bayer. She received honoraria from Takeda and Amgen for educational events and travel expenses from Servier, Shire, and Gilead. Alexander Towbin has received grants from Guerbet and the Cystic Fibrosis Foundation. He receives royalties from Elsevier. He has served as consultant for Applied Radiology, IBM Watson Health Imaging, and KLAS. Lucas Moreno has served in a consulting or advisory role for Novartis, AstraZeneca, Roche Genentech, Bayer, Amgen, and MundiPharma; has received honoraria for educational events from Celgene and Novartis; and has received travel expenses from MundiPharma, Celgene, and Amgen. The rest of the authors declare that they have no conflict of interest. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Publisher Copyright:
© 2020, Springer Science+Business Media, LLC, part of Springer Nature.
Keywords:
AYA oncology, CTCAE, Childhood cancer, Quality assurance, Quality of life, RECIST
Identifiers
Local EPrints ID: 437285
URI: http://eprints.soton.ac.uk/id/eprint/437285
ISSN: 0167-7659
PURE UUID: b7a61550-030e-4431-a699-d2d073d7b477
Catalogue record
Date deposited: 23 Jan 2020 17:34
Last modified: 17 Mar 2024 05:13
Export record
Altmetrics
Contributors
Author:
Teresa de Rojas
Author:
Anouk Neven
Author:
Alexander J. Towbin
Author:
Fernando Carceller
Author:
Francisco Bautista
Author:
David Riedl
Author:
Ana Fernandez-Teijeiro
Author:
Lucas Moreno
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
